Career Enhancement Program

职业提升计划

• 批准号: 8999527
• 负责人: GARY E GALLICK
• 金额: $ 7.52万
• 依托单位: UNIVERSITY OF TX MD ANDERSON CAN CTR
• 依托单位国家: 美国
• 财政年份: 2009
• 资助国家: 美国
• 起止时间: 2009-09-02 至 2021-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8999527
• 关键词: Applications Grants; Area; Award; Cancer Biology; Cancer Center; Cancer Research Project; Clinical; Communication; Critiques; Degree program; Development; Discipline; Doctor of Philosophy; Doctor' s Degree; Educational process of instructing; Electronics; Ensure; Evaluation; Faculty; Funding; Genitourinary system; Goals; Grant Review; Guidelines; Human; Individual; Institution; K-Series Research Career Programs; Laboratories; Laboratory Scientists; Leadership; Malignant neoplasm of prostate; Medical Oncologist; Mentors; Mentorship; Methods; Minority; Modification; Peer Review Grants; Physicians; Pilot Projects; Population; Principal Investigator; Process; Program Evaluation; Program Research Project Grants; Publications; Qualifying; Records; Recruitment Activity; Reporting; Research; Research Personnel; Research Project Grants; Schools; Science; Scientist; Series; Statistical Data Interpretation; Talents; Technical Expertise; Techniques; Texas; Training; Translational Research; United States National Institutes of Health; Universities; Woman; Work; Writing; anticancer research; base; career; educational atmosphere; experience; innovation; interest; meetings; member; organizational structure; programs; response; skills; success; translational study; web site

PROJECT SUMMARY (Career Enhancement Program) The goal of the Career Enhancement Program (CEP) of the MD Anderson Cancer Center Prostate Cancer SPORE (Prostate Cancer SPORE) is to develop a cadre of investigators dedicated to translational studies of human prostate cancer. It is directed by Dr. Gary E. Gallick and co-directed by Dr. Christopher J. Logothetis. The program will: 1) recruit innovative entry-level scientists to the Prostate Cancer SPORE to enhance the overall translational research capability of the SPORE and bring new techniques and talent to our program; 2) help these individuals develop the intellectual and technical skills required to be productive investigators in translational prostate cancer research; 3) teach these individuals basic principles of cancer biology not commonly included in clinical training or doctoral degree programs; and 4) guide the entry-level scientists in the development of competitive grant proposals in the area of translational prostate cancer research. The unique educational environment at MD Anderson will ensure that these goals will be met. At least two Career Enhancement awardees will be selected annually during the active funding period from qualified candidates within and outside MD Anderson who respond to a SPORE solicitation based on the defined criteria. Special emphasis will be placed on recruiting qualified women and members of minority populations whenever possible. In response to the previous critique, Dr. Logothetis will be actively involved in recruiting qualified physician/scientists to increase the number of MDs obtaining CEPs. Mentorship training will include principles of cancer biology, scientific methods, statistical analysis, biomedical communications, and strategies necessary to become successful in translational prostate cancer research. Several courses in The University of Texas Graduate School of Biomedical Sciences at Houston that encompass these disciplines are available to CEP recipients. The CEP recipients will be evaluated annually, and the selection process and training will be modified when appropriate. In addition, “upward” evaluation by recipients to their mentors will also occur annually, with modifications to the program made, as necessary, in response to input of CEP recipients (see Appendix “CEP Pilot Project Review Form” and “CEP Evaluation Form” for evaluation criteria). Nine Career Development awards (now Career Enhancement awards) have been funded by the Prostate Cancer SPORE. Investigators receiving CDP awards wrote 53 publications. A total of 25 externally reviewed grant applications were funded. Of note, Dr. Hui-Kuan Lin, a CDP awardee, will submit a Developmental Research Program (DRP) project to the SPORE, reflecting the synergistic relationship between the CEP and DRP mechanisms. Dr. Ana Aparicio, genitourinary medical oncologist, is a CEP awardee.

项目概要（职业提升计划） MD安德森癌症中心职业提升计划（CEP）的目标前列腺癌 孢子（前列腺癌孢子）是发展一个骨干的研究人员致力于翻译研究， 人类前列腺癌。由加里·E博士执导。导演：Christopher J. Logothetis博士 该计划将：1）招募创新的入门级科学家到前列腺癌孢子，以提高 SPORE的整体翻译研究能力，并为我们的计划带来新的技术和人才; 2） 帮助这些人发展成为富有成效的调查人员所需的智力和技术技能， 转化前列腺癌研究; 3）教这些人癌症生物学的基本原理， 通常包括在临床培训或博士学位课程;和4）指导入门级科学家， 在转化前列腺癌研究领域开发有竞争力的资助提案。的 MD安德森独特的教育环境将确保这些目标得以实现。至少两个职业 在积极资助期间，每年将从合格的候选人中选出增强奖获得者 MD安德森内部和外部根据定义的标准响应SPORE请求的人员。特别 在任何情况下，都将重点招聘合格的妇女和少数民族成员。 可能作为对之前批评的回应，Logothetis博士将积极参与招募合格的 医生/科学家增加获得CEP的MD数量。指导培训将包括原则 癌症生物学，科学方法，统计分析，生物医学通信和战略 在前列腺癌转化研究中取得成功所必需的。大学的几门课程 德克萨斯州休斯顿生物医学科学研究生院，包括这些学科， CEP接受者。CEP接受者将每年进行评估，选择过程和培训将 适当时进行修改。此外，受助人对导师的“向上”评价也会出现 根据CEP接受者的意见，对计划进行必要的修改（见 评价标准见附件《CEP试点项目评审表》和《CEP评价表》）。 9个职业发展奖（现为职业提高奖）由前列腺署资助。 癌症孢子。获得CDP奖项的研究人员撰写了53篇出版物。共25项外部审查 赠款申请得到资助。值得注意的是，CDP获奖者Hui-Kuan Lin博士将提交一份发展报告， 研究计划（DRP）项目到SPORE，反映了CEP和 DRP机制。Dr. Ana Aparicio，泌尿生殖内科肿瘤学家，是CEP获奖者。